Abstract
The E2F1 transcription factor is a well known regulator of cell proliferation and apoptosis, but its role in response to DNA damage is less clear. 8-Chloro-adenosine (8-Cl-Ado), a nucleoside analog, can inhibit proliferation in a variety of human tumor cells. However, it is still elusive how the agent acts on tumors. Here we show that A549 and H1299 cells formed DNA double-strand breaks after 8-Cl-Ado exposure, accompanied by E2F1 upregulation at protein level. Overexpressed wild-type (E2F1-wt) colocalized with double-strand break marker γ-H2AX and promoted G2/M arrest in 8-Cl-Ado-exposed A549 and H1299, while expressed S31A mutant of E2F1 (E2F1-mu) significantly reduced ability to accumulate at sites of DNA damage and G2/M arrest, suggesting that E2F1 is required for activating G2/M checkpoint pathway upon DNA damage. Transfection of either E2F1-wt or E2F1-mu plasmid promoted apoptosis in 8-Cl-Ado-exposed cells, indicating that 8-Cl-Ado may induce apoptosis in E2F1-dependent and E2F1-independent ways. These findings demonstrate that E2F1 plays a crucial role in 8-Cl-Ado-induced G2/M arrest but is dispensable for 8-Cl-Ado-induced apoptosis. These data also suggest that the mechanism of 8-Cl-Ado action is complicated.
Similar content being viewed by others
Abbreviations
- ATM:
-
ataxia telangiectasia mutated
- ATR:
-
ATM and Rad3-related kinase
- BRCA1:
-
breast cancer type 1 susceptibility protein
- CHK2:
-
checkpoint kinase 2
- 8-Cl-Ado:
-
8-chloro-adenosine
- 8-Cl-cAMP:
-
8-chloro-cAMP
- DSB:
-
double-strand break
- NER:
-
nucleotide excision repair
References
Halgren, R. G., Traynor, A. E., Pillay, S., Zell, J. L., Heller, K. F., Krett, N. L., and Rosen, S. T. (1998) Blood, 92, 2893–2898.
Carlson, C. C., Chinery, R., Burnham, L. L., and Dransfield, D. T. (2000) Neoplasia, 2, 441–448.
Gandhi, V., Ayres, M., Halgren, R. G., Krett, N. L., Newman, R. A., and Rosen, S. T. (2001) Cancer Res., 61, 5474–5479.
Ahn, Y. H., Jung, J. M., and Hong, S. H. (2005) Cancer Res., 65, 4896–4901.
Chen, L. S., and Sheppard, T. L. (2004) J. Biol. Chem., 279, 40405–40411.
Zhang, H. Y., Gu, Y. Y., Li, Z. G., Jia, Y. H., Yuan, L., Li, S. Y., An, G. S., Ni, J. H., and Jia, H. T. (2004) Neoplasia, 6, 802–812.
Gu, Y. Y., Zhang, H. Y., Zhang, H. J., Li, S. Y., Ni, J. H., and Jia, H. T. (2006) Biochem. Pharmacol., 72, 541–550.
Yang, S. Y., Jia, X. Z., Feng, L. Y., Li, S. Y., An, G. S., Ni, J. H., and Jia, H. T. (2009) Biochem. Pharmacol., 77, 433–443.
Jia, X. Z., Yang, S. Y., Zhou, J., Li, S. Y., Ni, J. H., An, G. S., and Jia, H. T. (2009) Biochem. Pharmacol., 77, 770–780.
Trimarchi, J. M., and Lees, J. A. (2002) Nat. Rev. Mol. Cell. Biol., 3, 11–20.
DeGregori, J., and Johnson, D. G. (2006) Curr. Mol. Med., 6, 739–748.
Stevaux, O., and Dyson, N. J. (2002) Curr. Opin. Cell. Biol., 14, 684–691.
Cam, H., and Dynlacht, B. D. (2003) Cancer Cell, 3, 311–316.
DeGregori, J. (2002) Biochim. Biophys. Acta, 1602, 131–150.
Iaquinta, P. J., and Lees, J. A. (2007) Curr. Opin. Cell. Biol., 19, 649–657.
Polager, S., Ofir, M., and Ginsberg, D. (2008) Oncogene, 27, 4860–4864.
Wang, B., Ling, S. Y., and Lin, W. C. (2010) PLoS One, 5, e10409.
Blattner, C., Sparks, A., and Lane, D. (1999) Mol. Cell. Biol., 19, 3704–3713.
Wei, Y. Y., Liu, D., Ge, Y. Q., Zhou, F. B., Xu, J. J., Chen, H., Gu, J. X., and Jiang, J. H. (2008) J. Biochem., 144, 539–546.
O’Connor, D. J., and Lu, X. (2000) Oncogene, 19, 2369–2376.
Lin, W. C., Lin, F. T., and Nevins, J. R. (2001) Genes Dev., 15, 1833–1844.
Stevens, C., Smith, L., and La Thangue, N. B. (2003) Nat. Cell. Biol., 5, 401–409.
Ianari, A., Gallo, R., Palma, M., Alesse, E., and Gulino, A. (2004) J. Biol. Chem., 279, 30830–30835.
Pediconi, N., Ianari, A., Costanzo, A., Belloni, L., Gallo, R., Cimino, L., Porcellini, A., Screpanti, I., Balsano, C., Alesse, E., Gulino, A., and Levrero, M. (2003) Nat. Cell. Biol., 5, 552–558.
Haroula, K., and Iannis, T. (2010) Mol. Cell, 39, 152–160.
Carcagno, A. L., Ogara, M. F., Sonzogni, S. V., Marazita, M. C., Sirkin, P. F., Ceruti, J. M., and Canepa, E. T. (2009) IUBMB Life, 61, 537–543.
Rogakou, E. P., Boon, C., Redon, C., and Bonner, W. M. (1999) J. Cell. Biol., 146, 905–915.
Liu, K., Lin, F. T., Ruppert, J. L., and Lin, W. C. (2003) Mol. Cell. Biol., 23, 3287–3304.
Frame, F. M., Rogoff, H. A., Pickering, M. T., Cress, W. D., and Kowalik, T. F. (2006) Oncogene, 25, 3258–3266.
Cerosaletti, K. M., and Concannon, R. (2003) J. Biol. Chem., 278, 21944–21951.
Guo, R., Chen, J., Zhu, F., Biswas, A. K., Berton, T. R., Mitchell, D. L., and Johnson, D. J. (2010) J. Biol. Chem., 285, 19308–19315.
Guo, R., Chen, J., Mitchell, D. L., and Johnson, D. G. (2011) Nucleic Acids Res., 39, 1390–1397.
Hallstrom, T. C., Mori, S., and Nevins, J. R. (2008) Cancer Cell, 13, 11–22.
Zhu, W., Giangrande, P. H., and Nevins, J. R. (2004) EMBO J., 23, 4615–4626.
DeGregori, J. (2002) Biochim. Biophys. Acta, 1602, 131–150.
Tsantoulis, P. K., and Gorgoulis, V. G. (2005) Eur. J. Cancer, 41, 2403–2414.
Molina-Privado, I., Rodriguez-Martinez, M., Rebollo, P., Martin-Perez, D., Artiga, M.-J., Menarguez, J., Flemington, E. K., Piris, M. A., and Campanero, M. R. (2009) Cancer Res., 69, 4052–4058.
Kuhn, H., Liebers, U., Gessner, C., Schumacher, A., Witt, C., Schauer, J., Kovesdi, I., and Wolff, G. (2002) Eur. Respir. J., 20, 703–709.
Polager, S., and Ginsberg, D. (2009) Nat. Rev. Cancer, 9, 738–748.
O’Connell, A. C., Lillibridge, C. D., Zheng, C., Baum, B. J., O’Connell, B. C., and Ambudkar, I. S. (1998) J. Cell. Physiol., 177, 264–273.
Liu, L., Li, J., Xu, Y. P., Qiao, W. T., Chen, Q. M., and Geng, Y. Q. (2009) Prog. Biochem. Biophys., 36, 541–548.
Zhang, H. J., Li, W. J., Yang, S. Y., Li, S. Y., Ni, J. H., and Jia, H. T. (2009) J. Cell. Biochem., 106, 464–472.
Grbovic, O., Jovic, V., Ruzdijic, S., Pejanovic, V., Rakic, L., and Kanazir, S. (2002) Cancer Invest., 20, 972–982.
Robinson-White, A. J., Bossis, I., Hsiao, H. P., Nesterova, M., Leitner, W. W., and Stratakis, C. A. (2009) J. Clin. Endocrinol. Metab., 94, 4061–4069.
Li, W. J., Gu, Y. Y., Zhang, H. J., Zhou, J., and Jia, H. T. (2009) Chemotherapy, 55, 335–343.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2012, Vol. 77, No. 3, pp. 330–341.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM11-224, January 22, 2012.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Duan, HY., Cao, JX., Qi, JJ. et al. E2F1 enhances 8-Chloro-adenosine-induced G2/M arrest and apoptosis in A549 and H1299 lung cancer cells. Biochemistry Moscow 77, 261–269 (2012). https://doi.org/10.1134/S0006297912030042
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297912030042